Ignite Creation Date:
2024-05-06 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05130866
Status:
RECRUITING
Last Update Posted:
2024-03-01
First Post:
2021-11-10
Brief Title:
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 NF2 Mutated Meningiomas
Sponsor:
Recursion Pharmaceuticals Inc
Organization:
Recursion Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-10
First Submit QC Date:
November 19 2021
Study First Post Date:
2021-11-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-29
Last Update Post Date:
2024-03-01
Last Update Post Date Type:
ACTUAL